Archive · 15 Dec 2025
Corona Remedies and Wakefit Solutions IPO Listings
Two companies, Corona Remedies and Wakefit Solutions, recently listed their shares on the stock market for the first time.
Corona Remedies, a pharmaceutical company, had a very successful debut.
Its shares started trading at a much higher price than what they were sold for during the IPO, making a big profit for early investors.
On the other hand, Wakefit Solutions, which sells home and sleep solutions, had a more modest debut.
Its shares started trading at a slightly lower price than the IPO price.
Corona Remedies raised ₹655.37 crore through its IPO, while Wakefit Solutions raised ₹1,288.89 crore.
Both companies will use the money raised to grow their businesses and cover various expenses.
Corona Remedies shares listed at a premium of 36.72% to 38.42% over the issue price on BSE and NSE.
Wakefit Solutions shares listed at a marginal discount of 0.46% to the issue price on BSE and at the issue price on NSE.
Corona Remedies IPO was oversubscribed 137.04 times, with strong participation from all investor categories.
Wakefit Solutions IPO received modest subscriptions, with overall subscriptions reaching 2.52 times, led by retail investors.
Corona Remedies raised ₹655.37 crore through its IPO, which was entirely an offer-for-sale (OFS).
Wakefit Solutions raised ₹1,288.89 crore through its IPO, including a fresh issue of ₹377.18 crore and an OFS of ₹911.71 crore.
- Who
- Corona Remedies and Wakefit Solutions
- What
- IPO listings
- When
- December 15
- Where
- BSE and NSE
- Why
- To raise funds for corporate purposes and expansion
Corona Remedies
Wakefit Solutions
Listing Performance
Corona Remedies
Corona Remedies shares listed at a premium of 36.72% to 38.42% over the issue price on BSE and NSE, making a strong debut.
Wakefit Solutions
Wakefit Solutions shares listed at a marginal discount of 0.46% to the issue price on BSE and at the issue price on NSE, making a muted debut.
Investor Demand
Corona Remedies
Corona Remedies IPO was oversubscribed 137.04 times, with strong participation from QIBs, NIIs, and retail investors.
Wakefit Solutions
Wakefit Solutions IPO received modest subscriptions, with overall subscriptions reaching 2.52 times, led by retail investors.
- Corona Remedies Listing Date
- December 15
- Corona Remedies Listing Exchanges
- BSE and NSE
- Corona Remedies Listing Price (NSE)
- ₹1,470
- Corona Remedies Listing Price (BSE)
- ₹1,452
- Corona Remedies Issue Price
- ₹1,062
- Corona Remedies Premium
- 36.72% to 38.42%
- Corona Remedies GMP
- ₹340-350
- Corona Remedies Total Funds Raised
- ₹655.37 crore
- Corona Remedies Subscription
- 137.04 times
- Wakefit Solutions Listing Date
- December 15
- Wakefit Solutions Listing Exchanges
- BSE and NSE
- Wakefit Solutions Listing Price (BSE)
- ₹194.10
- Wakefit Solutions Listing Price (NSE)
- ₹195
- Wakefit Solutions Issue Price
- ₹195
- Wakefit Solutions Discount
- 0.46%
- Wakefit Solutions GMP
- ₹4
- Wakefit Solutions Total Funds Raised
- ₹1,288.89 crore
- Wakefit Solutions Subscription
- 2.52 times
- Wakefit Solutions Fresh Issue
- ₹377.18 crore
- Wakefit Solutions OFS
- ₹911.71 crore
- Wakefit Solutions Lot Size
- 76 shares
- Wakefit Solutions Minimum Investment
- ₹14,820
Sources
Wakefit Innovations IPO listing tomorrow. Here's what GMP signals
Corona Remedies IPO: GMP ahead of listing signals strong debut for shares — Details here
Wakefit Solutions IPO To List Tomorrow: Check Here's What Latest GMP Suggests
Corona Remedies IPO listing date today. GMP, experts signal up to 27% listing gain on debut of shares
Wakefit Innovations IPO listing date today — What GMP experts signal about share debut
Park Medi IPO allotment to be finalised today. Here's GMP, step-by-step guide on how to check status online
Wakefit Innovations share disappoints on market debut; shares list at marginal discount
Wakefit Solutions share price makes muted debut, lists at IPO price of ₹195
Corona Remedies share price LIVE: Shares make bumper debut, list at 38% premium
Corona Remedies share price makes blockbuster debut; stock lists at ₹1,461 on NSE, up 37.57% from IPO price
Corona Remedies IPO: Check application status, allotment odds, GMP, listing date & more
Wakefit Innovations makes muted debut, lists at discount on BSE
Park Medi World IPO Allotment LIVE: GMP signals just 4% listing gains — Steps to track status online
Wakefit Innovations slid 9% to ₹177 level after muted listing
